Mycobacterium avium complex infection and Erythema multiforme

Summary:

Erythema multiforme is found among people with Mycobacterium avium complex infection, especially for people who are female, 40-49 old.

The study analyzes which people have Erythema multiforme with Mycobacterium avium complex infection. It is created by eHealthMe based on reports of 14 people who have Mycobacterium avium complex infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

14 people who have Mycobacterium Avium Complex Infection and Erythema Multiforme are studied.


What is Mycobacterium avium complex infection?

Mycobacterium avium complex infection is found to be associated with 670 drugs and 324 conditions by eHealthMe.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 2,789 drugs and 2,669 conditions by eHealthMe.

Number of Erythema multiforme in Mycobacterium avium complex infection reports submitted per year:

Would you have Erythema multiforme when you have Mycobacterium avium complex infection?

Gender of people who have Mycobacterium Avium Complex Infection and experienced Erythema Multiforme *:

  • female: 64.29 %
  • male: 35.71 %

Age of people who have Mycobacterium Avium Complex Infection and experienced Erythema Multiforme *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 10 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 40 %

Common co-existing conditions for these people *:

  1. Penicilliosis (infection caused by fungus penicillium marneffei): 3 people, 21.43%
  2. Hiv Infection: 3 people, 21.43%
  3. Herpes Zoster: 3 people, 21.43%
  4. Rosacea (a skin condition that causes facial redness): 2 people, 14.29%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 14.29%
  6. Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 1 person, 7.14%
  7. Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 7.14%
  8. Ill-Defined Disorder: 1 person, 7.14%
  9. Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 1 person, 7.14%

Common drugs taken by these people *:

  1. Clarithromycin: 5 people, 35.71%
  2. Valacyclovir: 4 people, 28.57%
  3. Stavudine: 3 people, 21.43%
  4. Efavirenz: 3 people, 21.43%
  5. Estazolam: 3 people, 21.43%
  6. Prednisolone: 3 people, 21.43%
  7. Mycobutin: 3 people, 21.43%
  8. Lamivudine: 3 people, 21.43%
  9. Vibramycin: 2 people, 14.29%
  10. Valsartan: 2 people, 14.29%

Common symptoms for these people *:

  1. Fever: 5 people, 35.71%
  2. Septic Shock (shock due to blood infection): 3 people, 21.43%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 21.43%
  4. Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 3 people, 21.43%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 21.43%
  6. Renal Impairment (severely reduced kidney function): 1 person, 7.14%
  7. Rashes (redness): 1 person, 7.14%
  8. Oral Mucosal Erythema (redness of the mucous membrane of mouth): 1 person, 7.14%
  9. Oral Mucosal Eruption (a sudden appearing of rash on mucous membrane of mouth): 1 person, 7.14%
  10. Malaise (a feeling of general discomfort or uneasiness): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Erythema multiforme?

Check whether Erythema multiforme is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Erythema multiforme:

Common drugs associated with Erythema multiforme:

All the drugs that are associated with Erythema multiforme:

Common conditions associated with Erythema multiforme:

All the conditions that are associated with Erythema multiforme:

How the study uses the data?

The study is based on Erythema multiforme and Mycobacterium avium complex infection, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: